Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04878029
What this trial is testing

Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma With Squamous DifferentiationLocally Advanced Urothelial CarcinomaMetastatic Urothelial Carcinoma+1 more
Emory University 32
Testing effectiveness (Phase 2)Ended earlyNCT03123055
What this trial is testing

B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Rainier Therapeutics 28
Large-scale testing (Phase 3)Study completedNCT00014534
What this trial is testing

Combination Chemotherapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Alliance for Clinical Trials in Oncology 42
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Testing effectiveness (Phase 2)UnknownNCT03209206
What this trial is testing

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 84
Early research (Phase 1)Study completedNCT03387761
What this trial is testing

Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy

Who this might be right for
Urothelial Carcinoma
The Netherlands Cancer Institute 54
Testing effectiveness (Phase 2)Looking for participantsNCT06696742
What this trial is testing

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT06364904
What this trial is testing

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 210
Post-approval studies (Phase 4)UnknownNCT05220124
What this trial is testing

Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

Who this might be right for
Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 190
Very early researchStudy completedNCT00734994
What this trial is testing

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

Who this might be right for
Transitional Cell Carcinoma of BladderSuperficial Bladder Cancer
Mark Dewhirst 15
Testing effectiveness (Phase 2)Looking for participantsNCT07061964
What this trial is testing

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
National Cancer Institute (NCI) 111
Not applicableStudy completedNCT04314245
What this trial is testing

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder Cancer
AnchorDx Medical Co., Ltd. 1,170
Testing effectiveness (Phase 2)Ended earlyNCT03007719
What this trial is testing

Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1

Who this might be right for
Bladder Cancer
Lawrence Fong 4
Testing effectiveness (Phase 2)Ended earlyNCT00003642
What this trial is testing

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 43
Not applicableStudy completedNCT03548688
What this trial is testing

Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:

Who this might be right for
Urothelial Carcinoma
British Urology Researchers in Surgical Training 11,059
Early research (Phase 1)Active Not RecruitingNCT05393427
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Urinary TumorsOther Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 4
Testing effectiveness (Phase 2)Study completedNCT03093922
What this trial is testing

Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

Who this might be right for
Urothelial CarcinomaLocally AdvancedUnresectable
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT03914794
What this trial is testing

Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Who this might be right for
Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Not applicableUnknownNCT01551342
What this trial is testing

Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology

Who this might be right for
Bladder Cancer Transitional Cell Carcinoma
Zetiq Technologies 500
Not applicableUnknownNCT04770974
What this trial is testing

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

Who this might be right for
Urothelial CarcinomaBladder CancerUrothelial Neoplasm+2 more
University of Florence 200
Next Page